Gyre Therapeutics, Inc. (GYRE) KPIs and segments
Close on Nov 18, 2026Market cap $483.95MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Gyre Therapeutics's business
Gyre Therapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gyre Pharmaceuticals($M) | 29.1 | 22.5 | 37.2 | 30.6 | 26.8 | 22.1 | 27.9 | 25.5 | 25.2 | 27.2 | 27.1 | 32.0 | |
Gyre($M) | 0.01 | 0 | 2.96 | 0 | |||||||||
Pharmaceutical Products($M) | 29.1 | 26.8 | |||||||||||
ETUARY($M) | 22.5 | 30.6 | 26.8 | 22.1 | 27.9 | 25.5 | 25.2 | 27.2 | 27.2 | 32 | |||
Gyre Pharmaceuticals($M) | -5.64 | 3.33 | |||||||||||
Gyre($M) | -8.62 | -5.57 | |||||||||||
Gyre Pharmaceuticals($M) | -3.07 | 3.16 | 8.87 | 4.23 | 3.74 | 2.24 | 6.05 | 4.35 | 9.39 | -0.50 | 12.8 | ||
Gyre($M) | -6.28 | -3.04 | -1.93 | -2.06 | -1.46 | -1.58 | -1.82 | -1.15 | -1.31 | ||||
Gyre Pharmaceuticals($M) | 26.9 | 21.3 | 35.5 | 28.9 | 25.6 | 21.2 | 26.7 | 24.5 | 24.5 | 26.2 | 25.9 | 30.9 | |
Gyre($M) | 0.01 | 0 | 2.96 | 0 | |||||||||
Gyre($M) | 0.49 | 0.67 | |||||||||||
Gyre Pharmaceuticals($M) | 0.25 | 0.27 | |||||||||||
Gyre($M) | -0.05 | 0 | -0.08 | 0 | 0 | 0 | 0 | -0.01 | |||||
Gyre Pharmaceuticals($M) | -0.21 | -0.18 | -0.14 | -0.67 | -0.26 | -0.12 | 0.07 | -0.69 | -1.46 | -0.22 | -2.32 | -1.97 | |
Gyre Pharmaceuticals($M) | 139 | 137 | 138 | 130 | 121 | 122 | 114 | 114 | 109 | 109 | 102 | ||
Gyre($M) | 59.7 | 24.3 | 81 | 29.0 | 31.1 | 7.07 | 10.8 | 10.6 | 10.5 | 11.8 | 13.9 | ||
Earlier reporting (last reported 2023)1 | |||||||||||||
3 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-07.
See a number that looks wrong?